ADVB
Advanced Biomed, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$6.54
−10.66%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.17x
- Price / sales
- —
- Price / cash flow
- -15.62x
Enterprise value
- Enterprise value
- $8.9M
- EV / sales
- —
- EV / EBITDA
- -8.87x
- EV / EBIT
- -8.14x
- Market cap
- $10.8M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026